EBioMedicine (Jun 2017)

The Role of Heterotypic DENV-specific CD8+T Lymphocytes in an Immunocompetent Mouse Model of Secondary Dengue Virus Infection

  • Laura B. Talarico,
  • Juan P. Batalle,
  • Alana B. Byrne,
  • Jorge M. Brahamian,
  • Adrián Ferretti,
  • Ayelén G. García,
  • Aldana Mauri,
  • Carla Simonetto,
  • Diego R. Hijano,
  • Andrea Lawrence,
  • Patricio L. Acosta,
  • Mauricio T. Caballero,
  • Yésica Paredes Rojas,
  • Lorena I. Ibañez,
  • Guillermina A. Melendi,
  • Félix A. Rey,
  • Elsa B. Damonte,
  • Eva Harris,
  • Fernando P. Polack

DOI
https://doi.org/10.1016/j.ebiom.2017.04.033
Journal volume & issue
Vol. 20, no. C
pp. 202 – 216

Abstract

Read online

Dengue is the most prevalent arthropod-borne viral disease worldwide and is caused by the four dengue virus serotypes (DENV-1-4). Sequential heterologous DENV infections can be associated with severe disease manifestations. Here, we present an immunocompetent mouse model of secondary DENV infection using non mouse-adapted DENV strains to investigate the pathogenesis of severe dengue disease. C57BL/6 mice infected sequentially with DENV-1 (strain Puerto Rico/94) and DENV-2 (strain Tonga/74) developed low platelet counts, internal hemorrhages, and increase of liver enzymes. Cross-reactive CD8+ T lymphocytes were found to be necessary and sufficient for signs of severe disease by adoptively transferring of DENV-1-immune CD8+T lymphocytes before DENV-2 challenge. Disease signs were associated with production of tumor necrosis factor (TNF)-α and elevated cytotoxicity displayed by heterotypic anti-DENV-1 CD8+ T lymphocytes. These findings highlight the critical role of heterotypic anti-DENV CD8+ T lymphocytes in manifestations of severe dengue disease.

Keywords